• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number SN60WF
Device Problem Insufficient Information (3190)
Patient Problems Bacterial Infection (1735); Chemosis (1775); Corneal Edema (1791); Endophthalmitis (1835); Hypopyon (1913); Retinal Detachment (2047); Loss of Vision (2139); Vitrectomy (2643)
Event Date 09/18/2017
Event Type  Injury  
Manufacturer Narrative
Product evaluation: the product was not returned for analysis.Results from the product history record review indicated the iol met release criteria.A root cause cannot be identified at this time.(b)(4).
 
Event Description
A surgeon reported via a health authority that a patient experienced an enterococcus faecalis infection four days following a cataract procedure with intraocular lens (iol) implant on her right eye (od).Endophthalmitis was observed with chemosis, retinal detachment, hypopyon, and corneal edema.The patient was hospitalized for nine days and treated with intravenous antibiotics.A vitrectomy was performed on (b)(6) 2017.It was noted that antibiotic eye drops had been prescribed since the first postoperative day.It was reported that the symptoms were continuing and that functional loss of the eye occurred.This is one of two reports being filed for the same facility.
 
Manufacturer Narrative
The product was not returned for investigation.We are unable to confirm the reported complaint.Based on the results from the product, batch and sterilization history record, the product met release criteria.There have been no other complaints for this lot.The manufacturer internal reference number is: (b)(4).
 
Event Description
Clarification was received, indicating that the reporting facility cannot determine which medical device may to have contributed to the event.It was noted that no samples can be provided.The surgery was uneventful, there were no new members of the sterilization team, and there had been no recent changes in procedures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ NATURAL SINGLEPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
nadia bailey
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8176152230
MDR Report Key7012170
MDR Text Key91410697
Report Number9612169-2017-00194
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model NumberSN60WF
Device Catalogue NumberSN60WF.180
Device Lot Number21155214
Other Device ID Number00380655093153
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/13/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/07/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age82 YR
-
-